TP53 and cardiomyopathy: In addition, in a mouse model, the western blot results revealed that the p53-related apoptotic pathway could be activated under DOX treatment, while overexpression of lnc5745 attenuated DOX-induced cardiomyopathy in vivo by suppressing p53-related signals, thus subsequently protecting cardiac function (Fig. 6e, f).